Standards; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides; Semi-Synthetic;
應用
The principal degradation product of Clindamycin 2-phosphate (C580005) in bulk drug and formulations. Clindamycin (C580000), is as semi-synthetic antibiotic prepared from Lincomycin. Antibacterial.
參考文獻
Birkenmeyer, R.D., et al.: J. Med. Chem., 13, 616 (1970), Oesterling, et al.: J. Pharm. Sci., 59, 63 (1970), Gray, J.E., et al.: Toxicol. Appl. Pharmacol., 21, 516 (1972), Brown, L.W., et al.: Anal. Profiles Drug Subs., 10, 75 (1981),
滬ICP備17019645號
400-821-0725
